Abstract
Reaching a value of close to $195 million by 2009, this market will experience
a CAGR of almost 25% between 2006 and 2009.
The global heart defect closure device market is composed of atrial septal
defect (ASD), patent foramen ovale (PFO), patent ductus arteriosus (PDA), and
ventricular septal defect (VSD) closures.